OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of $1.32 billion. The enterprise value is $1.44 billion.
| Market Cap | 1.32B |
| Enterprise Value | 1.44B |
Important Dates
The last earnings date was Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OPKO Health has 746.33 million shares outstanding. The number of shares has increased by 3.81% in one year.
| Current Share Class | 746.33M |
| Shares Outstanding | 746.33M |
| Shares Change (YoY) | +3.81% |
| Shares Change (QoQ) | -1.16% |
| Owned by Insiders (%) | 43.22% |
| Owned by Institutions (%) | 25.90% |
| Float | 323.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.02 |
| Forward PS | 2.48 |
| PB Ratio | 1.18 |
| P/TBV Ratio | 6.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.97, with a Debt / Equity ratio of 0.46.
| Current Ratio | 4.97 |
| Quick Ratio | 2.90 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.85 |
Financial Efficiency
Return on equity (ROE) is -8.90% and return on invested capital (ROIC) is -14.42%.
| Return on Equity (ROE) | -8.90% |
| Return on Assets (ROA) | -5.85% |
| Return on Invested Capital (ROIC) | -14.42% |
| Return on Capital Employed (ROCE) | -10.57% |
| Weighted Average Cost of Capital (WACC) | 11.16% |
| Revenue Per Employee | $287,515 |
| Profits Per Employee | -$65,079 |
| Employee Count | 2,275 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 9.11 |
Taxes
| Income Tax | -5.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.06% in the last 52 weeks. The beta is 1.53, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.53 |
| 52-Week Price Change | +28.06% |
| 50-Day Moving Average | 1.58 |
| 200-Day Moving Average | 1.35 |
| Relative Strength Index (RSI) | 67.48 |
| Average Volume (20 Days) | 5,676,418 |
Short Selling Information
The latest short interest is 34.01 million, so 4.56% of the outstanding shares have been sold short.
| Short Interest | 34.01M |
| Short Previous Month | 35.56M |
| Short % of Shares Out | 4.56% |
| Short % of Float | 10.51% |
| Short Ratio (days to cover) | 7.73 |
Income Statement
In the last 12 months, OPKO Health had revenue of $654.10 million and -$148.06 million in losses. Loss per share was -$0.20.
| Revenue | 654.10M |
| Gross Profit | 127.58M |
| Operating Income | -181.51M |
| Pretax Income | -113.18M |
| Net Income | -148.06M |
| EBITDA | -91.80M |
| EBIT | -181.51M |
| Loss Per Share | -$0.20 |
Balance Sheet
The company has $390.22 million in cash and $510.46 million in debt, with a net cash position of -$120.24 million or -$0.16 per share.
| Cash & Cash Equivalents | 390.22M |
| Total Debt | 510.46M |
| Net Cash | -120.24M |
| Net Cash Per Share | -$0.16 |
| Equity (Book Value) | 1.12B |
| Book Value Per Share | 1.50 |
| Working Capital | 643.92M |
Cash Flow
In the last 12 months, operating cash flow was -$125.05 million and capital expenditures -$10.29 million, giving a free cash flow of -$135.34 million.
| Operating Cash Flow | -125.05M |
| Capital Expenditures | -10.29M |
| Depreciation & Amortization | 89.71M |
| Net Borrowing | 123.14M |
| Free Cash Flow | -135.34M |
| FCF Per Share | -$0.18 |
Margins
Gross margin is 19.51%, with operating and profit margins of -27.75% and -22.64%.
| Gross Margin | 19.51% |
| Operating Margin | -27.75% |
| Pretax Margin | -17.30% |
| Profit Margin | -22.64% |
| EBITDA Margin | -14.03% |
| EBIT Margin | -27.75% |
| FCF Margin | n/a |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.81% |
| Shareholder Yield | -3.81% |
| Earnings Yield | -11.09% |
| FCF Yield | -10.24% |
Analyst Forecast
The average price target for OPKO Health is $4.15, which is 135.13% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.15 |
| Price Target Difference | 135.13% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | -0.07% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |